Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intuitive Remains Cautious For H2, Announces Extended Use Program For Instruments

Executive Summary

Intuitive reported better-than-expected second-quarter revenues and announced plans to roll out a new extended use program for certain surgical instruments, but remains cautious for the second half amid the COVID-19 pandemic. 

You may also be interested in...



Johnson & Johnson Unveils Details On Ottava Soft-Tissue Robot, Chasing Intuitive, Medtronic

J&J said its Ottava robotic platform has six robotic arms, “zero footprint,” and can be used for various procedures.

Medtech CEOs Predict Diminished Role For Hospitals In The Future Of Surgery

Surgical volumes are rebounding close to pre-pandemic levels, but the volumes at hospitals may never completely rebound, according to medtech CEOs participating in a discussion at The Virtual MedTech Conference.

J&J Bullish On Procedure Recovery As Q2 Device Sales Beat Analyst Expectations

Johnson & Johnson management said they expect medical device sales to make a quick recovery in the third and fourth quarter of 2020 after seeing a faster-than-expected reuptake of procedures during the second quarter.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT142480

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel